<p>Among central nervous system (CNS) tumors, gliomas are the most prevalent type of tumor. Single nucleotide polymorphisms (SNPs) in <i>telomerase reverse transcriptase</i> (<i>TERT</i>) gene have been identified as risk loci for gliomas by previous genome-wide association studies (GWAS). We examined association between <i>TERT</i> variants and glioma risk in a Korean population. For a case-control study, a total of 32 <i>TERT</i> SNPs from 317 patients with glioma and 480 population-based controls were genotyped. Logistic regression was used for statistical analysis of the link between <i>TERT</i> SNPs and risk of glioma. In this study, eight <i>TERT</i> variants, including four glioma-associated variants reported in previous studies, showed significant association with the risk of glioma. Conditional and stepwise analyses were conducted to validate independent associations in the group of the eight variants. Both analyses identified an intronic variant (<i>rs56345976</i>) as the causal variant among the eight variants. Glioma subgroup analyses indicate that <i>rs56345976</i> variant is associated with the risk of WHO grade 4, glioblastoma, <i>isocitrate dehydrogenase</i> (IDH) wild-type, and 1p/19q non-codeletion glioma. This study presents a profound comprehension of the relationship between <i>TERT</i> variants and the risk of glioma. Further studies of this variant are required to investigate its effect on glioma susceptibility.</p>